Advertisement
Screener

TransMedics Group, Inc. (TMDX) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

TransMedics Group, Inc. Amortization of Intangible Assets

TransMedics Group, Inc. (TMDX) reported Amortization of Intangible Assets of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-24

  • TransMedics Group, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $0.00.
  • TransMedics Group, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
  • TransMedics Group, Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $100.00K, a 0.00% change year-over-year.
  • TransMedics Group, Inc. amortization of intangible assets for the quarter ending 2025-03-31 was $100.00K, a 0.00% change year-over-year.
  • TransMedics Group, Inc. amortization of intangible assets for fiscal 2025 was $200.00K, a 0.00% change from fiscal 2024.
  • TransMedics Group, Inc. amortization of intangible assets for fiscal 2024 was $200.00K, a 100.00% increase from fiscal 2023.
  • TransMedics Group, Inc. amortization of intangible assets for fiscal 2023 was $100.00K.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$100.00K
derived: sum of 2 quarters · filed 2026-02-24
$200.00K
derived: sum of 3 quarters · filed 2026-02-24
$200.00K
10-K · filed 2026-02-24
2025-09-30$100.00K
10-Q · filed 2025-10-29
$200.00K
derived: sum of 2 quarters · filed 2025-10-29
$200.00K
10-Q · filed 2025-10-29
$300.00K
derived: sum of 4 quarters · filed 2026-02-24
2025-06-30$100.00K
10-Q · filed 2025-07-30
$100.00K
10-Q · filed 2025-07-30
$200.00K
derived: sum of 3 quarters · filed 2026-02-24
$300.00K
derived: sum of 4 quarters · filed 2026-02-24
2025-03-31$100.00K
10-Q · filed 2025-05-08
$100.00K
derived: sum of 2 quarters · filed 2026-02-24
$200.00K
derived: sum of 3 quarters · filed 2026-02-24
$300.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$100.00K
derived: sum of 2 quarters · filed 2026-02-24
$200.00K
derived: sum of 3 quarters · filed 2026-02-24
$200.00K
10-K · filed 2026-02-24
2024-09-30$100.00K
10-Q · filed 2025-10-29
$200.00K
derived: sum of 2 quarters · filed 2025-10-29
$200.00K
10-Q · filed 2025-10-29
2024-06-30$100.00K
10-Q · filed 2025-07-30
$100.00K
10-Q · filed 2025-07-30
2024-03-31$100.00K
10-Q · filed 2025-05-08
2023-12-31$100.00K
10-K · filed 2026-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53